Report Detail
COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2020-2026
- RnM4017600 |
- 09 June, 2020 |
- Global |
- 90 Pages |
- QYResearch |
- Pharma & Healthcare
This report focuses on the global Age-Related Macular Degeneration (AMD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Age-Related Macular Degeneration (AMD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
...
Market segment by Type, the product can be split into
Wet AMD
Dry AMD
Market segment by Application, split into
Hospital
Clinic
Research Institute
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Age-Related Macular Degeneration (AMD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Age-Related Macular Degeneration (AMD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Age-Related Macular Degeneration (AMD) Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Wet AMD
- 1.4.3 Dry AMD
- 1.5 Market by Application
- 1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Research Institute
- 1.5.5 Other
- 1.6 Coronavirus Disease 2019 (Covid-19): Age-Related Macular Degeneration (AMD) Therapeutics Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Age-Related Macular Degeneration (AMD) Therapeutics Industry
- 1.6.1.1 Age-Related Macular Degeneration (AMD) Therapeutics Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Age-Related Macular Degeneration (AMD) Therapeutics Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Age-Related Macular Degeneration (AMD) Therapeutics Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2015-2026)
- 2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
- 2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Share by Regions (2015-2020)
- 2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy
- 2.3.6 Primary Interviews with Key Age-Related Macular Degeneration (AMD) Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Market Size
- 3.1.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue (2015-2020)
- 3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio
- 3.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019
- 3.3 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
- 3.4 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service
- 3.5 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2015-2020)
- 4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2021-2026)
5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application (2015-2026)
- 5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
- 5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America (2019-2020)
- 6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe (2019-2020)
- 7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
8 China
- 8.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China (2019-2020)
- 8.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 8.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan (2019-2020)
- 9.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 9.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 10.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
11 India
- 11.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India (2019-2020)
- 11.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 11.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020)
- 12.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020)
- 12.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Amgen Inc.
- 13.1.1 Amgen Inc. Company Details
- 13.1.2 Amgen Inc. Business Overview and Its Total Revenue
- 13.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 13.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020))
- 13.1.5 Amgen Inc. Recent Development
- 13.2 Bausch Health Companies, Inc.
- 13.2.1 Bausch Health Companies, Inc. Company Details
- 13.2.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue
- 13.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 13.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
- 13.2.5 Bausch Health Companies, Inc. Recent Development
- 13.3 F. Hoffmann-La Roche Ltd.
- 13.3.1 F. Hoffmann-La Roche Ltd. Company Details
- 13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
- 13.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
- 13.3.5 F. Hoffmann-La Roche Ltd. Recent Development
- 13.4 Novartis AG
- 13.4.1 Novartis AG Company Details
- 13.4.2 Novartis AG Business Overview and Its Total Revenue
- 13.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 13.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
- 13.4.5 Novartis AG Recent Development
- 13.5 Regeneron Pharmaceuticals Inc.
- 13.5.1 Regeneron Pharmaceuticals Inc. Company Details
- 13.5.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue
- 13.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 13.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)
- 13.5.5 Regeneron Pharmaceuticals Inc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics. Industry analysis & Market Report on COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics is a syndicated market report, published as COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Age-Related Macular Degeneration (AMD) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
